Short description
ImmunoMet Therapeutics is a biopharmaceutical company that develops and commercializes oncology products for cancer patients.
Description
ImmunoMet Therapeutics is a development-stage biopharmaceutical company focused on the development and commercialization of novel oncology products that are aimed to improve the quality of life of cancer patients. With more than 6 years of experience in the field of cancer metabolism and immunometabolism, ImmunoMet has developed a comprehensive pipeline of metabolic regulators preferentially targeting the cellular metabolism of drug-resistant cancer subpopulations and immuno-suppressors of anti-cancer effector T cells.
Last funding
Uh Ohhhh
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Houston, Texas, United States, North America
Founded on
January 1, 2015
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noway Youcantaccess, Noaccess, Noaccessforu, Nopepepe, Noaccessforu, Uh Ohhhh, Absolutely Noaccess
Sign in for full access
Founders
Sungwuk Kim